Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026)
Si-Bone's (SIBN) quarterly Liabilities and Shareholders Equity came in at $242.7 million in Q1 2026, up 6.79% year-on-year from $227.3 million in Q1 2025, and up 1.75% quarter-over-quarter from $238.6 million in Q4 2025.
Si-Bone (SIBN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
Si-Bone's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $242.7 million for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 6.79% year-over-year to $242.7 million in Q1 2026; TTM through Mar 2026 was $946.5 million, a 4.17% increase from a year earlier, with the FY2025 full-year figure at $238.6 million, up 3.52% from the prior year.
- Liabilities and Shareholders Equity rose to $242.7 million in Q1 2026 per SIBN's latest filing, from $238.6 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $242.7 million in Q1 2026 and bottomed at $149.1 million in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $227.3 million (2025), against an average of $210.7 million.
- Across the five-year window, Liabilities and Shareholders Equity decreased 19.86% in 2022 and soared 50.07% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $157.6 million in 2022, then soared by 46.25% to $230.4 million in 2023, then gained by 0.01% to $230.4 million in 2024, then increased by 3.52% to $238.6 million in 2025, then rose by 1.75% to $242.7 million in 2026.
- Per Business Quant, the three latest SIBN Liabilities and Shareholders Equity figures stand at $242.7 million (Q1 2026), $238.6 million (Q4 2025), and $234.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | 242.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 242.72 Mn |
| Dec 31, 2025 | 238.56 Mn |
| Sep 30, 2025 | 234.27 Mn |
| Jun 30, 2025 | 230.92 Mn |
| Mar 31, 2025 | 227.28 Mn |
| Dec 31, 2024 | 230.44 Mn |
| Sep 30, 2024 | 227.00 Mn |
| Jun 30, 2024 | 223.84 Mn |
| Mar 31, 2024 | 223.71 Mn |
| Dec 31, 2023 | 230.43 Mn |
| Sep 30, 2023 | 230.88 Mn |
| Jun 30, 2023 | 233.83 Mn |
| Mar 31, 2023 | 149.08 Mn |
| Dec 31, 2022 | 157.55 Mn |
| Sep 30, 2022 | 158.27 Mn |
| Jun 30, 2022 | 166.15 Mn |
| Mar 31, 2022 | 176.85 Mn |
| Dec 31, 2021 | 190.51 Mn |
| Sep 30, 2021 | 193.97 Mn |
| Jun 30, 2021 | 207.33 Mn |